Photo de stock - 28 September 2023, Hesse, Frankfurt/Main: Management Board members, Supervisory Board members and guests of Schott AG and Schott Pharma celebrate the IPO of the pharmaceutical division of Mainz-based specialty glass manufacturer Schott on the floor of the stock exchange. The pharmaceutical division of Mainz-based specialty glass manufacturer Schott has arrived at the stock exchange. On Thursday morning, shares of the company were traded for the first time on the regulated market of the Frankfurt Stock Exchange in the so-called Prime Standard. The pharmaceutical division, which will be spun off in August 2022, produces, among other things, syringes made of glass and special glass plastic, ampoules and vials for the medical sector. The company hopes the IPO will generate proceeds of almost one billion euros. Photo: Arne Dedert/dpa. - Frankfurt/Main/Hesse/Germany

Photo de stock: 28 September 2023, Hesse, Frankfurt/Main: Management Board members, Supervisory Board members and guests of Schott AG and Schott Pharma celebrate the IPO of the.

Mots-clés utilisés

Choisir des mots clés multiples